PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 14, 125-138
- https://doi.org/10.2147/ott.s287931
Abstract
Purpose: Gliomas, characterized by aggressiveness and invasiveness, remain incurable after conventional therapies. The molecular mechanisms driving the progression and maintenance of glioma are still poorly understood. Methods: The TCGA and CGGA databases were chosen for bioinformatics analysis. Gene expression profiling interactive analysis (GEPIA) was performed for differential analysis. The Kaplan–Meier method was chosen for survival analysis. Analysis of stromal and immune infiltration was performed using the ESTIMATE algorithm and xCell package. qPCR and Western blotting were performed to measure the expression of PDIA4 at the mRNA and protein levels. IHC was performed to detect the expression of PDIA4 in glioma tissues. The viability of glioma cells was evaluated by the CCK8 assay. Results: In this study, we identified high PDIA4 expression in gliomas that correlated with poor prognosis. The association between IDH1 and different glioma patterns also indicated the potential biological role of PDIA4 in tumor development. Mechanistically, PDIA4 interacted with multiple immunological components to promote an immunosuppressive tumor microenvironment (TME). Knockdown of PDIA4 significantly impaired the proliferation of GBM cells. Conclusion: Our results confirm that PDIA4 is an efficient biomarker of gliomas, with clinical implications for prognosis and therapeutic strategies.Keywords
This publication has 42 references indexed in Scilit:
- The human protein disulfide isomerase gene familyPublished by Springer Science and Business Media LLC ,2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Separation and Identification of HSP-Associated Protein Complexes from Pancreatic Cancer Cell Lines Using 2D CN/SDS-PAGE Coupled with Mass SpectrometryJournal of Biomedicine and Biotechnology, 2011
- Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discoveryCancer Biology & Therapy, 2011
- Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposureBlood, 2010
- Protein disulfide isomerase as a trigger for tissue factor-dependent fibrin generationThrombosis Research, 2008
- Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILACProteomics, 2008
- Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activationJCI Insight, 2008
- Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57Nature Immunology, 2005
- Protein disulfide isomerase is essential for viability in Saccharomyces cerevisiaeGene, 1991